Protective effect of thioredoxin reductase 1 in Parkinson's disease
- PMID: 33171211
- DOI: 10.1016/j.neulet.2020.135457
Protective effect of thioredoxin reductase 1 in Parkinson's disease
Abstract
Parkinson's disease (PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra (SN). Many factors can explain the mechanism. However, the precise mechanism that contributes to the decreased number of dopaminergic neurons is unknown. Our study shows that oxidative stress is increased in models of PD compared with WT mice; Thioredoxin reductase 1(TR1) has emerged as an important antioxidant agent in dopaminergic neurons. In summary, our findings demonstrate that the overexpression of TR1 could be developed into a novel neuroprotective strategy for PD and that the reduction of the expression of GSK-3β and NF-κB could also be promising therapeutic strategies for PD. This research suggests a new direction in the treatment of PD.
Keywords: Apoptosis; Learning and memory; Olfactory; Parkinson's disease; Senescence; Thioredoxin reductase 1.
Copyright © 2020. Published by Elsevier B.V.
Similar articles
-
Overexpression of thioredoxin reductase 1 can reduce DNA damage, mitochondrial autophagy and endoplasmic reticulum stress in Parkinson's disease.Exp Brain Res. 2021 Feb;239(2):475-490. doi: 10.1007/s00221-020-05979-5. Epub 2020 Nov 23. Exp Brain Res. 2021. PMID: 33230666
-
Transcriptomic analysis: the protection of over-expression thioredoxin reductase 1 in Parkinson's disease.Chin Neurosurg J. 2023 Apr 3;9(1):9. doi: 10.1186/s41016-023-00319-2. Chin Neurosurg J. 2023. PMID: 37013627 Free PMC article.
-
Effect of Zishenpingchan granule prepared from Chinese medicinal substances on the c-Jun N-terminal protein kinase pathway in mice with Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.J Tradit Chin Med. 2017 Apr;37(2):244-51. doi: 10.1016/s0254-6272(17)30051-1. J Tradit Chin Med. 2017. PMID: 29960635
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
-
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?Parkinsonism Relat Disord. 2008;14 Suppl 2:S107-11. doi: 10.1016/j.parkreldis.2008.04.007. Epub 2008 Jun 27. Parkinsonism Relat Disord. 2008. PMID: 18585951 Review.
Cited by
-
The role of selenoproteins in neurodevelopment and neurological function: Implications in autism spectrum disorder.Front Mol Neurosci. 2023 Mar 9;16:1130922. doi: 10.3389/fnmol.2023.1130922. eCollection 2023. Front Mol Neurosci. 2023. PMID: 36969558 Free PMC article. Review.
-
Altered Cortical Palmitoylation Induces Widespread Molecular Disturbances in Parkinson's Disease.Int J Mol Sci. 2022 Nov 14;23(22):14018. doi: 10.3390/ijms232214018. Int J Mol Sci. 2022. PMID: 36430497 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
